Synucleinopathy: Clinical Trials

2 trials for Synucleinopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Recruiting 1

Follow Synucleinopathy: new trials by email Literature Review of Synucleinopathy trials Research Report on Synucleinopathy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tenapanor in Synucleinopathy-Related Constipation
Tenapanor, Placebo - Synucleinopathy, Parkinson's Disease
Phase 2RecruitingCedar Valley Digestive Health Center302025-01-012025-02-10
A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies
Idebenone, Placebo - Rapid Eye Movement Sleep Behavior Disorder, Synucleinopathy
Phase 2Active not recruitingRuijin Hospital282020-08-312025-11-25

Narrower conditions

Synucleinopathies (2)  ·  Constipation (1)  ·  Parkinson Disease (1)  ·  REM Sleep Behavior Disorder (1)

Broader conditions

Metabolic Diseases (2)  ·  Nervous System Diseases (2)  ·  Neurodegenerative Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Proteostasis Deficiencies (2)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Mental Disorders (1)  ·  Movement Disorders (1)  ·  Parasomnias (1)  ·  Parkinsonian Disorders (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  REM Sleep Parasomnias (1)  ·  Signs and Symptoms (1)

Interventions

idebenone (1)  ·  tenapanor (1)

Sponsors

Cedar Valley Digestive Health Center (1)  ·  Ruijin Hospital (1)

Countries

China (1)  ·  United States (1)

Top investigators

Harichandana Punukula, PharmD, MS (1)  ·  Ravindra Mallavarapu, MD (1)  ·  Richard A. Manfready, MD, AM, FACP (1)

Results publications

PMID 36172027